Zhang et al. reported that the combination of four mRNA biomarkers—KRAS, MBD3L2, ACRV1, and DPM1—in saliva supernatant could differentiate pancreatic cancer patients from non-cancer subjects [31]. The gene discussed is KRAS; the disease is familial pancreatic carcinoma.